Literature DB >> 9550731

Pap smear utilization in Canada: estimates after adjusting the eligible population for hysterectomy status.

J A Snider1, J E Beauvais.   

Abstract

The 1994 National Population Health Survey (NPHS) confirmed that the trend in Pap smear utilization has not changed in the past 10 years; 15% of Canadian women reported never having had a Pap smear and an additional 15% reported not having had one within 3 years prior to the survey. Most of these underserved women can be characterized as disadvantaged. The overall prevalence of hysterectomy in Canada in 1994 was 16.3%, and prevalence increased sharply to 30% between ages 35 and 55 years. Hysterectomy rates vary according to sociodemographic factors, with women of lower income and education indicating a higher proportion of hysterectomies. We adjusted the female population from the NPHS, by removing the estimated proportion of women reporting hysterectomy, to reveal the true population at risk of developing cervical cancer. Absolute prevalence of Pap smear utilization increased (7 - 25%); the relative improvement was much higher. Adjusting the eligible population could enable screening programs to better estimate the size of their underserved population.

Entities:  

Mesh:

Year:  1998        PMID: 9550731

Source DB:  PubMed          Journal:  Chronic Dis Can        ISSN: 0228-8699


  10 in total

1.  Factors important in promoting cervical cancer screening among Canadian women: findings from the 1996-97 National Population Health Survey (NPHS).

Authors:  C J Maxwell; C M Bancej; J Snider; S A Vik
Journal:  Can J Public Health       Date:  2001 Mar-Apr

2.  Cervical cancer mortality by neighbourhood income in urban Canada from 1971 to 1996.

Authors:  Edward Ng; Russell Wilkins; Michael Fung Kee Fung; Jean-Marie Berthelot
Journal:  CMAJ       Date:  2004-05-11       Impact factor: 8.262

3.  Cost-effectiveness of high-risk human papillomavirus testing for cervical cancer screening in Québec, Canada.

Authors:  Arthi Vijayaraghavan; Molly B Efrusy; Marie-Hélêne Mayrand; Christopher C Santas; Patricia Goggin
Journal:  Can J Public Health       Date:  2010 May-Jun

4.  Feasibility of self-collection of specimens for human papillomavirus testing in hard-to-reach women.

Authors:  Gina Ogilvie; Mel Krajden; Juanita Maginley; Judy Isaac-Renton; Greg Hislop; Ruth Elwood-Martin; Chris Sherlock; Darlene Taylor; Michael Rekart
Journal:  CMAJ       Date:  2007-08-28       Impact factor: 8.262

5.  Determining use of preventive health care in Ontario: comparison of rates of 3 maneuvers in administrative and survey data.

Authors:  Li Wang; X Nie Jason; Ross E G Upshur
Journal:  Can Fam Physician       Date:  2009-02       Impact factor: 3.275

6.  Psychosocial predictors of adherence to risk-appropriate cervical cancer screening guidelines: a cross sectional study of women in Ohio Appalachia participating in the Community Awareness Resources and Education (CARE) project.

Authors:  Electra D Paskett; John M McLaughlin; Paul L Reiter; Amy M Lehman; Dale A Rhoda; Mira L Katz; Erinn M Hade; Douglas M Post; Mack T Ruffin
Journal:  Prev Med       Date:  2009-09-08       Impact factor: 4.018

7.  [Use of pap smear for cervical cancer screening and factors related with its use in Spain].

Authors:  S Luengo Matos; A Muñoz van den Eynde
Journal:  Aten Primaria       Date:  2004-03-31       Impact factor: 1.137

8.  Transgender-inclusive measures of sex/gender for population surveys: Mixed-methods evaluation and recommendations.

Authors:  Greta R Bauer; Jessica Braimoh; Ayden I Scheim; Christoffer Dharma
Journal:  PLoS One       Date:  2017-05-25       Impact factor: 3.240

9.  The influence of total hysterectomy in a cervical cancer screening population: a register-based cross-sectional study.

Authors:  Mette Bach Larsen; Ellen M Mikkelsen; Ulla Jeppesen; Hans Svanholm; Berit Andersen
Journal:  BMC Health Serv Res       Date:  2017-06-20       Impact factor: 2.655

10.  Reduced cervical cancer incidence and mortality in Canada: national data from 1932 to 2006.

Authors:  James A Dickinson; Agata Stankiewicz; Cathy Popadiuk; Lisa Pogany; Jay Onysko; Anthony B Miller
Journal:  BMC Public Health       Date:  2012-11-16       Impact factor: 3.295

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.